Sequential nucleic acid and recombinant adenovirus vaccination induces host-protective immune responses against Taenia ovis infection in sheep

Parasite Immunology
J S RothelM W Lightowlers

Abstract

Sheep were immunized with a protective recombinant antigen (45W) from the cestode parasite Taenia ovis using three different vaccine delivery systems, either alone or in different combinations. The DNA encoding 45W was cloned into the expression plasmid pcDNA 3 and an ovine adenovirus to create nucleic acid and recombinant viral vector vaccines, respectively. Sheep received two vaccinations with various combinations of these two delivery systems and/or purified recombinant 45W protein in a conventional vaccine formulation containing Quil A as adjuvant (protein/Quil A vaccine). Sheep receiving two inoculations of either the nucleic acid or the recombinant adenovirus alone, demonstrated only low levels of 45W-specific antibody. However, immunization with either nucleic acid or recombinant adenovirus primed animals to mount an enhanced immune response after a subsequent vaccination with the protein/ Quil A vaccine. The most striking result was that sheep initially immunized with the nucleic acid vaccine and boosted with the recombinant adenovirus, mounted IgG1 responses > 65 fold higher than those of sheep receiving either vaccine alone. The level of antibody in these sheep was commensurate with that observed in animals vaccinated...Continue Reading

Citations

Mar 24, 2004·International Journal for Parasitology·D P Knox
Feb 27, 1999·International Journal for Parasitology·W D Smith
Sep 10, 1999·International Journal for Parasitology·M W Lightowlers
Nov 27, 1999·International Journal for Parasitology·A M Watts, R C Kennedy
Sep 6, 2000·Veterinary Immunology and Immunopathology·L A Babiuk van Drunnen Littel-van den Hur
Sep 1, 2000·Advanced Drug Delivery Reviews·B R Krishnan
Aug 28, 2001·Veterinary Parasitology·W Kofta, H Wedrychowicz
Nov 15, 2001·Veterinary Parasitology·M W Lightowlers, C G Gauci
Dec 3, 1999·Immunological Reviews·R M MaizelsM Yazdanbakhsh
Jun 24, 1998·Proceedings of the National Academy of Sciences of the United States of America·M SedegahS L Hoffman
Apr 14, 2004·Critical Reviews in Clinical Laboratory Sciences·Sharmila ManojSylvia van Drunen Littel-van den Hurk
Dec 24, 2005·Expert Opinion on Biological Therapy·Dongming Zhou, Hildegund C J Ertl
Sep 11, 2007·Journal of Comparative Pathology·G J Baird, M C Fontaine
Aug 19, 2007·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·A Crampton, T Vanniasinkam
Jun 6, 2009·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·Sara E Crager, Matt Price
Jun 5, 2003·Acta Tropica·M W Lightowlers
Nov 22, 2005·Vaccine·Dinesh S Bangari, Suresh K Mittal
Apr 14, 2006·Veterinary Research·Volker GerdtsLorne A Babiuk
May 23, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·M SedegahS L Hoffman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.